Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Johnson and Johnson
McKesson
Express Scripts
Boehringer Ingelheim

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

OXYCODONE AND ACETAMINOPHEN Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Oxycodone And Acetaminophen, and when can generic versions of Oxycodone And Acetaminophen launch?

Oxycodone And Acetaminophen is a drug marketed by Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart Inc, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Anda Repository, Ascent Pharms Inc, Aurolife Pharma Llc, Elite Labs Inc, Epic Pharma Llc, Lannett Co Inc, Mayne Pharma Inc, Mikart, Nesher Pharms, Novel Labs Inc, Rhodes Pharms, Sun Pharm Inds Inc, Wes Pharma Inc, and Xiromed. and is included in forty-nine NDAs.

The generic ingredient in OXYCODONE AND ACETAMINOPHEN is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

Drug patent expirations by year for OXYCODONE AND ACETAMINOPHEN
Recent Clinical Trials for OXYCODONE AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwestern UniversityPhase 4
University of Massachusetts, WorcesterPhase 4
William Beaumont HospitalsPhase 4

See all OXYCODONE AND ACETAMINOPHEN clinical trials

Pharmacology for OXYCODONE AND ACETAMINOPHEN
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Synonyms for OXYCODONE AND ACETAMINOPHEN
330988-72-2
Acetaminophen mixture with Oxycodone
DTXSID10186763
Magnacet
Oxycodone mixture with Acetaminophen
Primlev
SCHEMBL2521418

US Patents and Regulatory Information for OXYCODONE AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 210079-003 Dec 28, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 201972-003 Jul 15, 2013 AA RX No No   Start Trial   Start Trial   Start Trial
Anda Repository OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 207834-001 Aug 15, 2019 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Mallinckrodt
Express Scripts
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.